 |
Amily |
|
Emily |
|
Lily |
159-2642-3062
服務熱線（工作日：9:00-17:30）
武漢科斯坦生物科技有限公司
熱搜詞：燕窩酸，不飽和脂肪酸，神經酰胺，花青素，黃酮，皂苷
Wuhan Chemstan Biotechnology Co., Ltd.
武漢科斯坦生物科技有限公司
-
在線咨詢 -
官方郵箱 -
微信下單
-
回到頂部
代謝組學
科研服務
抗體/蛋白
地 址：武漢市東湖新技術開發區高新大道666號，武漢
國家生物產業基地B、C、D區研發樓C1棟
產品銷售：15926423062
技術服務：18971263062
E - mail ：info@chemstan.com
郵 編：430075
化合物單體
科斯坦生物（Chemstan）所有產品和服務僅用于科學研究，不為任何個人或者非科研性質的用途提供產品和服務。
Copyright @ 武漢科斯坦生物科技有限公司.All rights reserved
網站建設：中企動力武漢鄂ICP備19006850號-1
瀏覽量:
產品名稱：
Research Grade Narsoplimab (納索利單抗 )
NO.
013
貨號：
CSD00525
中文名稱
納索利單抗
英文名詞
Research Grade Narsoplimab
CAS號
2108782-45-0
產品貨號：
CSD00525
貨期：
現貨
價格與訂購：
2480.00
數量：
-
+
庫存：
100
產品信息
如何訂購
貨號（Catalog No.）icon
CSD00525
通用名INNicon
Narsoplimab
純度(Purity)icon
>95%
濃度( Concentration)icon
1mg/ml
Formulationicon
PBS buffer PH7.5
Sourceicon
CHO cells
內毒素(Endotoxin level)icon
Please contact with the lab for this information.
產品描述(Description)icon
Narsoplimab is a human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), the effector enzyme of the lectin pathway of the complement system. The lectin pathway is one of the principal pathways of complement and is activated primarily by tissue damage and microbial infection. Importantly, inhibition of MASP-2 does not appear to interfere with the classical complement pathway, a critical component of the acquired immune response to infection. This novel, proprietary drug is designed to prevent complement-mediated inflammation and endothelial damage while leaving intact the respective functions of the other pathways of innate immunity.
別名(Alternative names)icon
OMS721
靶點;物種(Specificity target name;species)icon
MASP2[Homo sapiens]
種類(Species)icon
Homo sapiens
受體鑒定(Receptor identification)icon
IgG4-lambda
CASicon
2108782-45-0
存儲條件(Storage)icon
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Noteicon
For research use only .
上一篇
Research Grade Pembrolizumab ( 帕博利珠單抗 )
Research Grade Tocilizumab ( 托珠單抗 )
下一篇